3297 |
Final Answer RESTORE |
Jung-Min Ahn |
Apr. 20. 15 |
3296 |
EVT for Femoro-popliteal Diseases with Misago Stent: 2-yaer Outcomes in the Real-world 88 Patients |
Shuichi Seki |
Apr. 20. 15 |
3295 |
How to Treat In-Stent Restenosis: DEB vs. DES |
Alaide Chieffo |
Apr. 20. 15 |
3294 |
What Can We Look Forward to from the Magnesium Scaffold? |
Ron Waksman |
Apr. 20. 15 |
3293 |
Use of Drug Coated Balloons in Coronary Intervention: Where No Stent Is the Best Stent. |
Paul JL Ong |
Apr. 20. 15 |
3292 |
Drug-coated Balloon: Established Indications and Beyond |
Paul JL Ong |
Apr. 20. 15 |
3291 |
New DES Lower DES Failure?: In-Stent Restenosis and Stent Thrombosis in New DES |
Imad Sheiban |
Apr. 20. 15 |
3290 |
Safety and Efficacy of an Ultrathin-strut SES with Bioabsorbable Polymer Coating |
Giulio G. Stefanini |
Apr. 20. 15 |
3289 |
Neoatherosclerosis in New DES: Insight from Intracoronary Imaging |
Soo-Jin Kang |
Apr. 20. 15 |
3288 |
Experience of BVS in Complex Lesions |
Corrado Tamburino |
Apr. 20. 15 |